2016-03-25 | Downgrade | Brean Capital | Buy to Hold | |
2015-11-11 | Reiterated Rating | Brean Capital | Buy | $32.81 |
2015-10-08 | Downgrade | Goldman Sachs | Buy to Neutral | $31.00 to $33.00 |
2015-10-08 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $31.00 to $33.00 |
2015-08-14 | Boost Price Target | JPMorgan Chase & Co. | $29.00 to $32.00 | |
2015-08-12 | Lower Price Target | Brean Capital | Buy | $39.00 to $32.81 |
2015-05-13 | Lower Price Target | Brean Capital | Buy to Buy | $47.00 to $39.00 |
2015-03-13 | Downgrade | Credit Suisse | Outperform to Underperform | $38.00 to $20.90 |
2015-03-13 | Downgrade | Credit Suisse Group AG | Outperform to Underperform | $38.00 to $20.90 |
2015-03-12 | Downgrade | TH Capital | Buy to Hold | |
2015-03-12 | Reiterated Rating | Brean Capital | Buy | $47.00 |
2014-08-13 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $46.00 to $43.00 |
2014-05-13 | Upgrade | Macquarie | Neutral to Outperform | |
2014-05-13 | Reiterated Rating | Morgan Stanley | Average to Equal Weight | $35.00 |
2014-05-13 | Lower Price Target | Brean Capital | Buy | $54.00 to $47.00 |
2014-03-13 | Boost Price Target | Brean Capital | $50.00 to $54.00 | |
2013-11-18 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $40.00 to $46.00 |
2013-11-18 | Boost Price Target | T.H. Capital | Buy | $37.00 to $50.00 |
2013-11-15 | Boost Price Target | Brean Capital | Buy | $42.00 to $50.00 |
2013-10-10 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | |
2012-03-09 | Reiterated | Brean Murray | Buy | $44 to $41 |
2011-05-03 | Reiterated | Oppenheimer | Outperform | $42 to $48 |
2010-11-11 | Reiterated | Brean Murray | Buy | $50 to $55 |
2010-04-01 | Initiated | Roth Capital | Buy | $42 |
2009-05-13 | Upgrade | Oppenheimer | Perform to Outperform | $20 |
2009-02-17 | Upgrade | Brean Murray | Hold to Buy | |
2008-02-26 | Upgrade | Susquehanna Financial | Neutral to Positive | |
2007-10-30 | Downgrade | Brean Murray | Buy to Hold | |
2007-10-29 | Initiated | Susquehanna Financial | Negative | |
2007-10-24 | Reiterated | Deutsche Securities | Buy | $39 to $56 |
2007-10-05 | Initiated | Citigroup | Buy | $46 |
2007-07-17 | Reiterated | Brean Murray | Buy | $36 to $38 |
2007-06-07 | Initiated | Brean Murray | Buy | $36 |
2007-04-02 | Initiated | CIBC Wrld Mkts | Sector Perform | $40 |
2016-03-25 | Downgrade | Brean Capital | Buy to Hold | |
2015-11-11 | Reiterated Rating | Brean Capital | Buy | $32.81 |
2015-10-08 | Downgrade | Goldman Sachs | Buy to Neutral | $31.00 to $33.00 |
2015-10-08 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $31.00 to $33.00 |
2015-08-14 | Boost Price Target | JPMorgan Chase & Co. | $29.00 to $32.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HMIN 2 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
MANAGED ACCOUNT ADVISORS LLC | 47239 |
Index Management Solutions, LLC | 97 |